Xu X J, Tang M M, Chen Q W, Shi J T, Han L, Jiang B
Department of Head and Neck Surgery, Affiliated Cancer Hospital of Nantong University, Nantong 226361, China.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024 Mar 7;59(3):238-242. doi: 10.3760/cma.j.cn115330-20230814-00046.
To investigate the efficacy of V-Y advancement flap with facial artery perforator for the repair of midface skin defects. A retrospective analysis was performed on 18 patients with facial skin cancer, including 11 males and 7 females, aged 65-83 years, who underwent the repair of midface skin defects using V-Y advancement flap with facial artery perforator in the Department of Head and Neck Surgery, Affiliated Cancer Hospital of Nantong University from January 2020 to April 2023. Medium, large or complex midface skin defects developed after surgical resections of the primary lesions. According to the defect site, size, location information of facial vessels, a V-Y advancement flap with appropriate shape was designed for each case. During the operation, the facial vessels and their perforators were retained in the pedicle of the flap, the facial nerve branches were dissected and protected, and the further denuded pedicle was determined according to actual amount of advancement. After the flap was advanced, the facial defect area was repaired without tension, and the anatomical positions and functions of the eyes, nose and mouth were restored as far as possible. Postoperative follow-ups were conducted to observe the survival rate of the flaps, postoperative complications, recurrences and metastases of tumors. Midface defects of 3.0 cm×3.5 cm-6.5 cm×7.5 cm were observed after tumor resections, which involved one or more subregions. The sizes of the flaps were 3.5 cm×9.0 cm-7.0 cm×18.0 cm. All flaps were completely alive except for one with temporary local bruising. With following-up of 4-40 months, 5 of the 12 patients with lower eyelid and inner canthus invasions had lower eyelid ectropion, but no exposed keratitis was found; one case with poorly differentiated squamous cell carcinoma had lymph node metastasis in the submandibular region and underwent neck dissection again; no recurrence or metastasis occurred in the remaining cases. The V-Y advancement flap with facial artery perforator can be used to repair medium, large or complex midface skin defects, with a high survival rate, and the operation method is safe and reliable.
探讨面动脉穿支V-Y推进皮瓣修复面中部皮肤缺损的疗效。对2020年1月至2023年4月在南通大学附属医院头颈外科采用面动脉穿支V-Y推进皮瓣修复面中部皮肤缺损的18例面部皮肤癌患者进行回顾性分析。其中男性11例,女性7例,年龄65 - 83岁。原发灶手术切除后出现中、大或复杂的面中部皮肤缺损。根据缺损部位、大小、面部血管位置信息,为每例患者设计合适形状的V-Y推进皮瓣。手术中,皮瓣蒂部保留面血管及其穿支,解剖并保护面神经分支,根据实际推进量确定进一步游离的蒂部。皮瓣推进后,无张力修复面部缺损区,尽可能恢复眼、鼻、口的解剖位置和功能。术后进行随访,观察皮瓣成活率、术后并发症、肿瘤复发及转移情况。肿瘤切除后可见3.0 cm×3.5 cm - 6.5 cm×7.5 cm的面中部缺损,累及一个或多个亚区域。皮瓣大小为3.5 cm×9.0 cm - 7.0 cm×18.0 cm。除1例出现暂时性局部瘀斑外,所有皮瓣均完全成活。随访4 - 40个月,12例下睑及内眦侵犯患者中有5例出现下睑外翻,但未发现暴露性角膜炎;1例低分化鳞状细胞癌患者下颌下区出现淋巴结转移,再次行颈部清扫术;其余病例未出现复发或转移。面动脉穿支V-Y推进皮瓣可用于修复中、大或复杂的面中部皮肤缺损,成活率高,手术方法安全可靠。